跳至主要内容
临床试验/CTRI/2018/07/014787
CTRI/2018/07/014787已完成3 期

A prospective, open label, randomized controlled trial to evaluate the effect of intravenous vitamin C, Thiamine and Hydrocortisone treatment on all cause mortality among patients with severe sepsis and septic shock. - ViCTOR

Amrita Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients admitted to ICU with :
  • 1)primary diagnosis of sepsis/septic shock as determined based on SSC 2012 guidelines.
  • 2)Patients > 18 years of age

排除标准

  • 1)Patients < 18 years age
  • 2)Pregnancy
  • 3)Patients with limitations of care
  • (advanced disease with malignancy)
  • 5)Acute liver failure

研究者

相似试验